India To Weed Out Over 300 Fixed-Dose Combos; Next Round In Court
This article was originally published in Scrip
Executive Summary
India has clamped down on the country's burgeoning market for irrational fixed-dose combinations (FDCs), weeding out more than 300 such products – a move that is seen as denting the industry sharply but being welcomed by physicians given the lack of therapeutic rationale for most of these medicines and the growing challenge of drug resistance in the case of anti-infectives.